Provigil Judge Says Experts Can Testify On Patent Strength
A Philadelphia federal judge ruled Thursday that drugmakers could use evidence at an upcoming pay-for-delay antitrust trial over Provigil about the strength of the narcolepsy drug patent if purchasers argue that...To view the full article, register now.
Already a subscriber? Click here to view full article